ArticleCardiology research2022

A Significant Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients With Type 2 Diabetes.

Hidekatsu Yanai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.